Fair Pricing Forum – 2017 Meeting Report

Amsterdam, The Netherlands, 11 May 2017

by Beurs van Berlage
World Health Organization

15 pp. 4.9 MB

The main aim of the Forum was to enable stakeholders to discuss options for a fairer pricing system that is sustainable for both health systems and the pharmaceutical industries.

The Forum sought to address three questions:

  • What can governments do to ensure fairer medicines prices and greater access?
  • What can industry do?
  • How can WHO support the process?

Key issues addressed included: developing alternative approaches for research and development (R&D) and business models for innovation; facilitating collaboration among payers by expanding current networks to include other relevant stakeholders and countries; increasing exchange of information, for example to assess the value of new products; promoting transparency of prices paid, R&D costs, production costs, and profit margins.

(Visited 15 times, 1 visits today)
This entry was posted in Development Assistance, Essential Medicines, General. Bookmark the permalink.